A conversation around what the future holds for AI, the insurer mix shift, and more.
With bid season approaching, payers' pharmacy teams must re-evaluate how to competitively position themselves for success.
How extended periods of suppressed utilization and a regulatory pause on record collection may influence plans' anticipated results next year.
Considerations for the pricing of health insurance products amidst a global crisis.
Four tactical considerations to ensure your pandemic reaction is expedited, purposeful, and meaningful.
By 2030, 20% of the US will be over 65. Boomers represent the biggest, most lucrative MA growth segment.
Why a focus on the provider is needed to achieve 4 or 5 Stars.
New analysis details how far ‘all in’ provider organizations have to go to reap risk rewards.
Details on the final Call Letter and advice for where plans should place their strategic focus in 2018.
CMS Star Ratings are do-or-die for health plans. And this year, the bar is higher than ever. Our latest analysis finds that a health plan’s Star rating is defined primarily by the behavior of its providers.